Effects of erythropoietin administration on cerebral metabolism and exercise capacity in men.

Effects of erythropoietin administration on cerebral metabolism and exercise capacity in men / P. Rasmussen, E.M. Foged, R. Krogh-Madsen, J. Nielsen, T.R. Nielsen, N.V. Olsen, N.C. Petersen, T.A. Sørensen, N.H. Secher, C. Lundby. - (Journal of Applied Physiology 109 (2010) 2 (August); p. 476-483)

  • PMID: 20522733
  • DOI: 10.1152/japplphysiol.00234.2010


Abstract

Recombinant human erythropoietin (EPO) increases exercise capacity by stimulating erythropoiesis and subsequently enhancing oxygen delivery to the working muscles. In a large dose, EPO crosses the BBB and may reduce central fatigue and improve cognition. In turn, this would augment exercise capacity independent of erythropoiesis. To test this hypothesis, 15 healthy young men (18-34 years old, 74 + or - 7 kg) received either 3 days of high-dose (30,000 IU/day; n = 7) double-blinded placebo controlled or 3 mo of low-dose (5,000 IU/wk; n = 8) counter-balanced open but controlled administration of EPO. We recorded exercise capacity, transcranial ultrasonography-derived middle cerebral artery blood velocity, and arterial-internal jugular venous concentration differences of glucose and lactate. In addition, cognitive function, ratings of perceived exertion, ventilation, and voluntary activation by transcranial magnetic stimulation-induced twitch force were evaluated. Although EPO in a high dose increased cerebrospinal fluid EPO concentration approximately 20-fold and affected ventilation and cerebral glucose and lactate metabolism (P < 0.05), 3 days of high-dose EPO administration had no effect on cognition, voluntary activation, or exercise capacity, but ratings of perceived exertion increased (P < 0.05). We confirmed that 3 mo of administration of EPO increases exercise capacity, but the improvement could not be accounted for by other mechanisms than enhanced oxygen delivery. In conclusion, EPO does not attenuate central fatigue or change cognitive performance strategy, suggesting that EPO enhances exercise capacity exclusively by increased oxygen delivery to the working muscles.

Original document

Parameters

Science
Research / Study
Date
1 August 2010
People
Foged, E.M.
Krogh-Madsen, R.
Lundby, Carsten
Nielsen, T.R.
Olsen, N.V.
Petersen, N.C.
Rasmussen, Peter
Secher, Niels H.
Sørensen, T.A.
Country
Denmark
Switzerland
Language
English
Other organisations
Rigshospitalet - Danish National Hospital
Universität Zürich (UZH) - University of Zurich
Doping classes
S2. Peptide Hormones, Growth Factors
Substances
Erythropoietin (EPO)
Medical terms
Health effects
Document category
Scientific article
Document type
Pdf file
Date generated
28 February 2012
Date of last modification
18 January 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin